ID

13589

Descrição

T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS); ODM derived from: https://clinicaltrials.gov/show/NCT00242515

Link

https://clinicaltrials.gov/show/NCT00242515

Palavras-chave

  1. 18/02/2016 18/02/2016 -
Titular dos direitos

CC BY-NC 3.0

Transferido a

18 de fevereiro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Acute Myeloid Leukemia NCT00242515

Eligibility Acute Myeloid Leukemia NCT00242515

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. confirmed diagnosis of aml or high risk mds in the following disease stages: induction failure, first or subsequent remission, or untreated first relapse.
Descrição

1. confirmed diagnosis of aml or high risk mds in the following disease stages: induction failure, first or subsequent remission, or untreated first relapse.

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023467
UMLS CUI [2]
C3463824
UMLS CUI [3,1]
C3179010
UMLS CUI [3,2]
C0162643
UMLS CUI [4]
C0544452
UMLS CUI [5]
C0277556
2. patient must have an hla-compatible donor willing and capable of donating peripheral blood stem cells preferably or bone marrow progenitor cells using conventional techniques, and lymphocytes if indicated (hla-compatible defined as 5/6 or 6/6 matched related or 6/6 molecular matched unrelated donor)
Descrição

2. patient must have an hla-compatible donor willing and capable of donating peripheral blood stem cells preferably or bone marrow progenitor cells using conventional techniques, and lymphocytes if indicated (hla-compatible defined as 5/6 or 6/6 matched related or 6/6 molecular matched unrelated donor)

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0013018
UMLS CUI [1,2]
C2348930
UMLS CUI [2]
C1518999
UMLS CUI [3]
C0596993
3. both patient and donor must sign written informed consent forms.
Descrição

3. both patient and donor must sign written informed consent forms.

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
ecog ps </= 2;
Descrição

ecog ps </= 2;

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
ejective fraction > 40%;
Descrição

ejective fraction > 40%;

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232174
dlco > 40% of predicted;
Descrição

dlco > 40% of predicted;

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1516251
serum bilirubin </= 1.5x institutional upper limit of normal;
Descrição

serum bilirubin </= 1.5x institutional upper limit of normal;

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1278039
sgpt (alt) and sgot (ast) </= 2.5x institutional upper limit of normal;
Descrição

sgpt (alt) and sgot (ast) </= 2.5x institutional upper limit of normal;

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
serum creatinine </= 2x upper limit of normal;
Descrição

serum creatinine </= 2x upper limit of normal;

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201976
creatinine clearance >/= 60ml/min. however, renal dysfunction is not an absolute contraindication for nmt as dialysis can be performed during nmt.
Descrição

creatinine clearance >/= 60ml/min. however, renal dysfunction is not an absolute contraindication for nmt as dialysis can be performed during nmt.

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0373595
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. not fulfilling any of the inclusion criteria
Descrição

1. not fulfilling any of the inclusion criteria

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1512693
2. active life-threatening infection
Descrição

2. active life-threatening infection

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0009488
3. overt untreated infection
Descrição

3. overt untreated infection

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0009488
4. hiv positivity, hepatitis b or c antigen positivity with active hepatitis
Descrição

4. hiv positivity, hepatitis b or c antigen positivity with active hepatitis

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019682
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
5. pregnant or lactating women
Descrição

5. pregnant or lactating women

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
6. donor contraindication (hiv seropositive confirmed by western blot; hepatitis b antigenemia)
Descrição

6. donor contraindication (hiv seropositive confirmed by western blot; hepatitis b antigenemia)

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0013018
UMLS CUI [1,2]
C0019682
UMLS CUI [2,1]
C0013018
UMLS CUI [2,2]
C0019163
7. unable to donate bone marrow or peripheral blood due to concurrent medical condition
Descrição

7. unable to donate bone marrow or peripheral blood due to concurrent medical condition

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C1305211
UMLS CUI [3]
C0229664

Similar models

Eligibility Acute Myeloid Leukemia NCT00242515

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
aml or high risk mds
Item
1. confirmed diagnosis of aml or high risk mds in the following disease stages: induction failure, first or subsequent remission, or untreated first relapse.
boolean
C0023467 (UMLS CUI [1])
C3463824 (UMLS CUI [2])
C3179010 (UMLS CUI [3,1])
C0162643 (UMLS CUI [3,2])
C0544452 (UMLS CUI [4])
C0277556 (UMLS CUI [5])
hla-compatible donor
Item
2. patient must have an hla-compatible donor willing and capable of donating peripheral blood stem cells preferably or bone marrow progenitor cells using conventional techniques, and lymphocytes if indicated (hla-compatible defined as 5/6 or 6/6 matched related or 6/6 molecular matched unrelated donor)
boolean
C0013018 (UMLS CUI [1,1])
C2348930 (UMLS CUI [1,2])
C1518999 (UMLS CUI [2])
C0596993 (UMLS CUI [3])
written informed consent
Item
3. both patient and donor must sign written informed consent forms.
boolean
C0021430 (UMLS CUI [1])
ECOG
Item
ecog ps </= 2;
boolean
C1520224 (UMLS CUI [1])
ejection fraction
Item
ejective fraction > 40%;
boolean
C0232174 (UMLS CUI [1])
dlco
Item
dlco > 40% of predicted;
boolean
C1516251 (UMLS CUI [1])
bilirubin
Item
serum bilirubin </= 1.5x institutional upper limit of normal;
boolean
C1278039 (UMLS CUI [1])
ALT and AST
Item
sgpt (alt) and sgot (ast) </= 2.5x institutional upper limit of normal;
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
creatinine
Item
serum creatinine </= 2x upper limit of normal;
boolean
C0201976 (UMLS CUI [1])
Creatinine Clearance
Item
creatinine clearance >/= 60ml/min. however, renal dysfunction is not an absolute contraindication for nmt as dialysis can be performed during nmt.
boolean
C0373595 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
inclusion criteria
Item
1. not fulfilling any of the inclusion criteria
boolean
C1512693 (UMLS CUI [1])
life-threatening infection
Item
2. active life-threatening infection
boolean
C0009488 (UMLS CUI [1])
overt untreated infection
Item
3. overt untreated infection
boolean
C0009488 (UMLS CUI [1])
HIV, hepatitis b or c
Item
4. hiv positivity, hepatitis b or c antigen positivity with active hepatitis
boolean
C0019682 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
pregnancy or lactation
Item
5. pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
donor contraindication
Item
6. donor contraindication (hiv seropositive confirmed by western blot; hepatitis b antigenemia)
boolean
C0013018 (UMLS CUI [1,1])
C0019682 (UMLS CUI [1,2])
C0013018 (UMLS CUI [2,1])
C0019163 (UMLS CUI [2,2])
unable to donate bone marrow or peripheral blood due to concurrent medical condition
Item
7. unable to donate bone marrow or peripheral blood due to concurrent medical condition
boolean
C0009488 (UMLS CUI [1])
C1305211 (UMLS CUI [2])
C0229664 (UMLS CUI [3])

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial